KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Non Operating Income: 2009-2025

Historic Non Operating Income for Neogenomics (NEO) over the last 12 years, with Sep 2025 value amounting to -$335,000.

  • Neogenomics' Non Operating Income fell 205.68% to -$335,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$219,000, marking a year-over-year decrease of 224.43%. This contributed to the annual value of -$379,000 for FY2024, which is 158.85% down from last year.
  • Latest data reveals that Neogenomics reported Non Operating Income of -$335,000 as of Q3 2025, which was down 169.50% from $482,000 recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Non Operating Income peaked at $730,000 during Q2 2023, and registered a low of -$4.9 million during Q1 2021.
  • Its 3-year average for Non Operating Income is $43,364, with a median of -$2,000 in 2024.
  • In the last 5 years, Neogenomics' Non Operating Income tumbled by 2,276.68% in 2021 and then spiked by 24,200.00% in 2025.
  • Over the past 5 years, Neogenomics' Non Operating Income (Quarterly) stood at -$930,000 in 2021, then skyrocketed by 99.89% to -$1,000 in 2022, then soared by 12,500.00% to $124,000 in 2023, then slumped by 447.58% to -$431,000 in 2024, then crashed by 205.68% to -$335,000 in 2025.
  • Its last three reported values are -$335,000 in Q3 2025, $482,000 for Q2 2025, and $65,000 during Q1 2025.